Becton, Dickinson and Company has struggled over the past decade, with a 10-year CAGR of only 5.1%. Read what keeps me on the ...

The FDA shared an alert that BD (NYSE: BDX) and its Bard subsidiary warned customers of an issue with certain intravascular ...

Valued at a market cap of $57.1 billion, Becton, Dickinson and Company (BDX) is a global medical technology company that ...

The EXTRAClean Exosomal RNA Isolation Kit produces high-quality RNA that improves results from small RNA sequencing and ...

Piper Sandler analyst Jason Bednar lowered the firm’s price target on Becton Dickinson to $260 from $280 and keeps an Overweight rating on the ...

The BD Accuri™ C6 is a personal flow cytometer that brings flow cytometry within reach by being easy to use, simple to maintain, and affordable. The analytical power and versatility of today’s ...

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Becton Dickinson (BDX – Research Report), ...

The FDA has issued a safety warning regarding a potentially high-risk issue involving certain BD PowerPICC Intravascular Catheters. The affected devices are 4 Fr. Single Lumen PowerPICC catheters, ...

Eli Lilly said on Wednesday it had sued four compounders for selling unapproved products containing tirzepatide, after a U.S.

Steel notched two assists and three hits in Monday's 4-3 overtime win over the Avalanche in Game 2. The Stars leaned on their depth to even the series at one game apiece, and Steel was a big part ...